News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CeNeS Pharmaceuticals PLC (CEN.L) Files IND for Lead Product M6G


3/28/2007 5:21:29 PM

CAMBRIDGE, UK 28 March 2007 - CeNeS Pharmaceuticals plc (AIM: CEN) the Cambridge based biopharmaceutical company, announces the filing of its first Investigational New Drug ("IND") application with the US Food and Drug Administration ("FDA") to commence clinical studies in the US with morphine-6-glucuronide ("M6G"), its novel drug for the treatment of post-operative pain.

Read at PharmaLive

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES